SENOKOT

This brand name is authorized in Australia, Ecuador, Hong Kong, Ireland, Mexico, New Zealand, Singapore, Turkey, United Kingdom, South Africa

Active ingredients

The drug SENOKOT contains one active pharmaceutical ingredient (API):

1 Sennosides UNII 3FYP5M0IJX - SENNOSIDES

The sugar moiety of the sennosides is removed by bacteria in the large intestine releasing the active anthrone fraction. This stimulates peristalsis via the submucosal and myenteric nerve plexuses. Read about Sennosides

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
SENOKOT Syrup	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
A06AB06	Senna glycosides	A Alimentary tract and metabolism → A06 Laxatives → A06A Laxatives → A06AB Contact laxatives
Discover more medicines within A06AB06

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 4455L
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 02096-MAE-12-03
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 102688, 154425, 33879, 33883, 387142, 387518, 388718, 45518, 95504, 95540
Country: HK	Department of Health Drug Office	Identifier(s): 56454
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 093M91, 51727
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 105
Country: SG	Health Sciences Authority	Identifier(s): 04731P
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8690570015508, 8699543010427
Country: ZA	Health Products Regulatory Authority	Identifier(s): 28/11.5/0644, A40/11.5/0050, E/11.5/671